Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: A long-term and integrative study

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 12, 1997, Pages 1300-1311

  Chagoya De Sánchez, Victoria ^a   Hernández Muñoz, Rolande ^a   López Barrera, Fernando ^a   Yañez, Lucía ^a   Vidrio, Susana ^a   Suárez, Jorge ^b   Cota Garza, Ma Dolores ^b   Aranda Fraustro, Alberto ^b   Cruz, David ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Cardiotoxicity; Heart energy balance; Heart mitochondria; Myocardial ischemia; Physiopathology; Telemetry system

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; BIOCHEMICAL MARKER; CREATINE; CREATINE PHOSPHATE; ISOPRENALINE;

ACUTE HEART INFARCTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENERGY METABOLISM; ENZYME ASSAY; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART RATE; HISTOLOGY; HYPOTENSION; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT; ULTRASTRUCTURE;

EID: 0031415328     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-154     Document Type: Article

References (34)

1. Atkinson, D.E. 1968. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry, 7: 4030-4034.
2. Baroldi, G. 1975. Different types of myocardial necrosis in coronary heart disease: a pathophysiologic review of their functional significance. Am. Heart J. 89: 742-752.
3. Bergmeyer, H.U., and Bernt, E. 1965. Glutamate-oxaloacetate transaminase. Colorimetric determination with 2,4-dinitrophenyl-hydrazine. In Methods of enzymatic analysis. Edited by H.U. Bergmeyer. Academic Press, New York.
4. Brockway, B.P., and Hassier, C.R. 1993. Application of radiotelemetry to cardiovascular measurements in pharmacology and toxicology. In New technologies and concepts for reducing drug toxicities. Edited by H. Salem and S.I. Baskin. CRC Press, Boca Raton, Fla. pp. 109-132.
5. Dolgov, V.V. 1975. Role of adrenaline in the changes of ion and energy metabolism in the cardiac mitochondria in experimental myocardial infarct. Kardiologiya, 15: 111-117.
6. Hernández-Muñoz, R., Díaz-Muñoz, M., and Chagoya de Sánchez, V. 1992. Effect of adenosine administration on the function and membrane composition of liver mitochondria in carbon tetrachloride-induced cirrhosis. Arch. Biochem. Biophys. 294: 160-167.
7. Hoffman, N.E., and Liao, J.C. 1977. Reversed phase high performance liquid Chromatographic separations of nucleotides in the presence of solvophobic ions. Anal. Chem. 49: 2231-2234.
8. Juengling, E., and Kammermeier, H. 1980. Rapid assay of adenine nucleotides and creatine compounds in extracts of cardiac tissue by paired-ion reverse-phase high-performance liquid chromatography. Anal. Biochem. 102: 358-361.
9. Kammermeier, H. 1987. Why do cells need phosphocreatine and a phosphocreatine shuttle. J. Mol. Cell. Cardiol. 19: 115-118.
10. Kammermeier, H., Schmidt, P., and Jüngling, E. 1982. Free energy change of ATP hydrolysis: a causal factor of early hypoxic failure of the myocardium?. J. Mol. Cell. Cardiol. 14: 267-277.
11. Kapelko, V.I., Kupriyanov, V.V., Novikova, N.A., Lakomkin, V.L., Steinschneider, A.Y., Severina, M.Y., Veksler, V.I., and Saks, V.A. 1988. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency. J. Mol. Cell. Cardiol. 20: 465-479.
12. Karmazyn, M. 1991. Ischemic and reperfusion injury in the heart. Cellular mechanisms and pharmacological interventions. Can. J. Physiol. Pharmacol. 69: 719-730.
13. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
14. Ma, X.-L., Baraona, E., Hernández-Muñoz, R., and Lieber, C.S. 1989. High levels of acetaldehyde in nonalcoholic liver injury after threonine and ethanol administration. Hepatology, 10: 933-940.
15. Nicholls, D.G. 1982. Quantitative bioenergetics. The measurement of driving forces. In Bioenergetics. Edited by D.G. Nicholls. Academic Press, London, pp. 41-63.
16. Rafael, J. 1983. Cytochrome c oxidase. In Methods of enzymatic analysis. Vol. 3. Edited by H.U. Bergmeyer and J. Bergmeyer. Verlag Chemie, Weinheim, Germany, pp. 266-273.
17. Regitz, V., Paulson, D.J., Hodach, R.J., Little, S.E., Schaper, W., and Shug, A.L. 1984. Mitochondrial damage during myocardial ischemia. Basic Res. Cardiol. 79: 207-217.
18. Rona, G. 1985. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17: 291-306.
19. Rona, G., Chappel, C.I., Balazs, T., and Gaudry, R. 1959. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch. Pathol. 67: 443-455.
20. Singal, P.K., Kapur, N., Dhillon, K.S., Beamish, R.E., and Dhalla, N.S. 1982. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60: 1390-1397.
21. Singh, J., Garg, K.N., Garg, D., and Lal, H. 1988. Effect of adenosine and inosine on experimental myocardial infarction in rats. Indian J. Exp. Biol. 26: 771-774.
22. Stanton, H.C., Brenner, G., and Mayfield, E.D. 1969. Studies on isoproterenol-induced cardiomegaly in rats. Am. Heart J. 77: 72-80.
23. Suárez, J., and Rubio, R. 1991. Regulation of glycolytic flux by coronary flow in guinea pig heart. Role of vascular endothelial cell glycocalyx. Am. J. Physiol. 261: H1994-H2000.
24. Todd, G.L., Baroldi, G., Pieper, G.M., Clayton, F.C., and Eliot, R.S. 1985a. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J. Mol. Cell. Cardiol. 17: 317-338.
25. Todd, G.L., Baroldi, G., Pieper, G.M., Clayton, F.C., and Eliot, R.S. 1985b. Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced contraction band lesions correlated with ECG, hemodynamic and biochemical changes. J. Mol. Cell. Cardiol. 17: 647-656.
26. Tse, J., Powell, J.R., Baste, C.A., Priest, R.E., and Kuo, J.F. 1979. Isoproterenol-induced cardiac hypertrophy: modifications in characteristics of β-adrenergic receptor, adenylate cyclase. and ventricular contraction. Endocrinology, 105: 246-255.
27. Tunstall-Pedoe, H.K., Kuulasmaa, P., Amouyel, D., Aerveiller, A.M., Rajakangas, A., and Pajak, A. 1994. Myocardial infarction and coronary deaths in the World Health Organization Monica Project. Circulation, 90: 583-612.
28. Uyemura, S.A., and Curti, C. 1991. Respiration and mitochondrial ATPase in energized mitochondria during isoproterenol-induced cell injury of myocardium. Int. J. Biochem. 23: 1143-1149.
29. Valcarce, C., Navarrete, R.M., Encabo, P., Loeches, E., Satrústegui, J., and Cuezva, J.M. 1988. Postnatal development of rat liver mitochondrial functions. J. Biol. Chem. 263: 7767-7775.
30. Vleeming, W., van Rooij, H.H., Wemer, J., and Porsius, A.J. 1990. Modulation of adrenoreceptor-mediated cardiovascular effects by short-term in vivo infusion of isoproterenol in rats. J. Cardiovasc. Pharmacol. 16: 584-593.
31. Whitty, A.J., Dimino, M.J., Elfont, E.A., Hughes, G.W., and Repack, M.W. 1976. Transmural mitochondrial differences in myocardium. Recent Adv. Stud. Card. Struct. Metab. 11: 349-354.
32. Wittels, E.H., Hay, J.W., and Gotto, A.M. 1990. Medical costs of coronary artery disease in the United States. Am. J. Cardiol. 65: 432-440.
33. Zimmer, H.G., and Ibel, H. 1983. Effect of ribose on cardiac metabolism in isoproterenol-treated rats. Am. J. Physiol. 245: H880-H886.
34. Zimmer, H.G., and Schneider, A. 1991. Nucleotide precursors modify the effects of isoproterenol. Circ. Res. 69: 1575-1582.